Search Results - "Cywin, Charles L"
-
1
National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward
Published in Neurotherapeutics (01-10-2017)Get full text
Journal Article -
2
Design, Synthesis, and Evaluation of Nonretinoid Retinol Binding Protein 4 Antagonists for the Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease
Published in Journal of medicinal chemistry (25-09-2014)“…Accumulation of lipofuscin in the retina is associated with pathogenesis of atrophic age-related macular degeneration and Stargardt disease. Lipofuscin…”
Get full text
Journal Article -
3
Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease
Published in Journal of medicinal chemistry (13-08-2015)“…Antagonists of retinol-binding protein 4 (RBP4) impede ocular uptake of serum all-trans retinol (1) and have been shown to reduce cytotoxic bisretinoid…”
Get full text
Journal Article -
4
A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket
Published in Nature structural biology (01-04-1997)“…The crystal structure of human p38 mitogen-activated protein (MAP) kinase in complex with a potent and highly specific pyridinyl-imidazole inhibitor has been…”
Get full text
Journal Article -
5
Hit to Lead Account of the Discovery of a New Class of Inhibitors of Pim Kinases and Crystallographic Studies Revealing an Unusual Kinase Binding Mode
Published in Journal of medicinal chemistry (09-04-2009)“…A series of inhibitors of Pim-2 kinase identified by high-throughput screening is described. Details of the hit validation and lead generation process and…”
Get full text
Journal Article -
6
Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity
Published in Journal of medicinal chemistry (14-03-1997)“…Meloxicam (5), an NSAID in the enol−carboxamide class, was developed on the basis of its antiinflammatory activity and relative safety in animal models. In…”
Get full text
Journal Article -
7
Evolution of the Thienopyridine Class of Inhibitors of IκB Kinase-β: Part I: Hit-to-Lead Strategies
Published in Journal of medicinal chemistry (18-05-2006)“…High-throughput screening is routinely employed as a method for the identification of novel hit structures. Large numbers of active compounds are typically…”
Get full text
Journal Article -
8
Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors
Published in Bioorganic & medicinal chemistry letters (01-07-2007)“…Benzimidazole 1 was identified as a selective inhibitor of ITK by high throughput screening. Hit-to-lead studies defined the SAR at all three substituents…”
Get full text
Journal Article -
9
Rapid synthesis of an array of trisubstituted urea-based soluble epoxide hydrolase inhibitors facilitated by a novel solid-phase method
Published in Bioorganic & medicinal chemistry letters (15-06-2010)“…Rapid exploration of multi-dimensional SAR around a series of trisubstituted urea inhibitors of sEH was accomplished using a focused library approach. A…”
Get full text
Journal Article -
10
Discovery of potent and selective PKC-θ inhibitors
Published in Bioorganic & medicinal chemistry letters (2007)“…An uHTS campaign was performed to identify selective inhibitors of PKC-θ. Initial triaging of the hit set based on selectivity and historical analysis led to…”
Get full text
Journal Article -
11
Substituted 2H-isoquinolin-1-one as potent Rho-Kinase inhibitors. Part 1: Hit-to-lead account
Published in Bioorganic & medicinal chemistry letters (01-06-2010)“…Two closely related scaffolds were identified through an uHTS campaign as desirable starting points for the development of Rho-Kinase (ROCK) inhibitors. Here,…”
Get full text
Journal Article -
12
Hit to Lead Account of the Discovery of Bisbenzamide and Related Ureidobenzamide Inhibitors of Rho Kinase
Published in Journal of medicinal chemistry (28-01-2010)“…A highly selective series of bisbenzamide inhibitors of Rho-associated coiled-coil forming protein kinase (ROCK) and a related ureidobenzamide series, both…”
Get full text
Journal Article -
13
5-Aminomethyl-1H-benzimidazoles as orally active inhibitors of inducible T-cell kinase (Itk)
Published in Bioorganic & medicinal chemistry (15-10-2008)“…A series of novel 5-aminomethyl-1H-benzimidazole based inhibitors of Itk were prepared. Structure-activity relationships, selectivity and cell activity are…”
Get full text
Journal Article -
14
Design and Synthesis of Dipeptide Nitriles as Reversible and Potent Cathepsin S Inhibitors
Published in Journal of medicinal chemistry (05-12-2002)“…The specificity of the immune response relies on processing of foreign proteins and presentation of antigenic peptides at the cell surface. Inhibition of…”
Get full text
Journal Article -
15
Discovery and SAR of novel [1,6]Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)
Published in Bioorganic & medicinal chemistry letters (17-04-2003)“…The discovery of novel 5,7-disubstituted[1,6]naphthyridines as potent inhibitors of Spleen Tyrosine Kinase (SYK) is discussed. The SAR reveals the necessity…”
Get full text
Journal Article -
16
An orally active reversible inhibitor of cathepsin S inhibits human trans vivo delayed-type hypersensitivity
Published in European journal of pharmacology (24-05-2006)“…Cathepsin S is a major histocompatibility complex (MHC) class II associated invariant chain (Ii) degrading enzyme expressed in antigen presenting cells such as…”
Get full text
Journal Article -
17
The design of potent hydrazones and disulfides as cathepsin S inhibitors
Published in Bioorganic & medicinal chemistry (06-03-2003)“…The design and synthesis of dipeptidyl disulfides and dipeptidyl benzoylhydrazones as selective inhibitors of the cysteine protease Cathepsin S are described…”
Get full text
Journal Article -
18
Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 7. 8-Arylethyldipyridodiazepinones as Potent Broad-Spectrum Inhibitors of Wild-Type and Mutant Enzymes
Published in Journal of medicinal chemistry (30-07-1998)“…Like other nonnucleoside inhibitors of HIV-1 reverse transcriptase, the dipyridodiazepinone nevirapine (Viramune, 1) selects for drug resistant variants of…”
Get full text
Journal Article -
19
Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 8. 8-Aryloxymethyl- and 8-Arylthiomethyldipyridodiazepinones
Published in Journal of medicinal chemistry (30-07-1998)“…Nevirapine (I) is the first human immunodeficiency virus type 1 (HIV-1) nonnucleoside reverse transcriptase (RT) inhibitor to reach regulatory approval. As a…”
Get full text
Journal Article -
20
Design and Synthesis of Dipeptide Nitriles as Reversible and Potent Cathepsin S Inhibitors
Published in Journal of medicinal chemistry (27-02-2003)Get full text
Journal Article